Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with advanced rectal cancer (a type of cancer in the last part of the large intestine) that has spread to nearby tissues or lymph nodes in specific ways, such as growing into surrounding structures, being very close to certain surgical margins, spreading to particular lymph nodes, or showing signs of cancer in nearby blood vessels
- People whose cancer also involves lymph nodes along the pelvic sidewall may optionally be considered (confirm with trial site)
- People who are largely able to carry out daily activities with little or no restriction (as assessed by a doctor using a standard scale)
- People who are willing and able to give their full written consent to participate
Who may not be able to join:
- People who have previously received any treatment for rectal cancer
- People who have previously had radiation therapy to the pelvic area for any reason, such as prostate cancer
- People who have a hip replacement (hip prosthesis)
- People who are unable to have an MRI scan for any reason
- People who are pregnant
- People who have a certain genetic variation affecting how the body processes a specific type of chemotherapy drug (known as an abnormal DPYD genotype)
- People who have a known medical reason why they cannot safely receive certain chemotherapy drugs used in this trial (5-FU, Capecitabine, or Oxaliplatin), as determined by the treating doctors
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Unn Hege Lilleøren, MD, Dept. of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway
Phone: 95890659
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of acute gastro-intestinal toxicity equal or higher than grade 2
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.